Alnylam announces promotion of dr. akshay vaishnaw to president

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, today announced that akshay vaishnaw, m.d., ph.d. has been appointed president. dr. vaishnaw joined alnylam in 2006 as vice president, clinical research with roles of increasing responsibility, ultimately serving as president of research and development (r&d). in this new role, dr. vaishnaw will serve as the key scientific leader of alnylam and will advance the company's r
ALNY Ratings Summary
ALNY Quant Ranking